Australian Pharmaceutical Industries Ltd (API.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 08-2011 | 08-2010 | 08-2009 | 08-2008 | 04-2007 | |
| Sales | 3,425,890 | 3,713,312 | 3,549,734 | 3,238,879 | 2,648,989 |
| Cost of Goods | 3,056,098 | 3,338,186 | 3,180,802 | 2,875,540 | 2,321,396 |
| Gross Profit | 369,792 | 375,126 | 368,932 | 363,339 | 327,593 |
| Operating Expenses | 354,845 | 348,381 | 341,703 | 325,323 | 333,032 |
| Operating Income | 14,947 | 26,745 | 27,229 | 38,016 | -5,439 |
| Interest Expense | 27,604 | 25,898 | 25,345 | 31,740 | 23,850 |
| Other Income | -17,320 | 34,821 | 25,292 | 14,693 | 13,446 |
| Pre-tax Income | -29,977 | 35,668 | 27,176 | 20,969 | -15,843 |
| Income Tax | -6,667 | 13,022 | 8,578 | 5,756 | -4,358 |
| Net Income Continuous | -23,310 | 22,646 | 18,598 | 15,213 | -11,485 |
| Minority Interests | N/A | N/A | N/A | N/A | 215 |
| Net Income | $-23,310 | $22,646 | $18,598 | $15,213 | $-11,270 |
| EPS Basic Total Ops | -0.05 | 0.05 | 0.06 | 0.05 | -0.04 |
| EPS Basic Continuous Ops | -0.05 | 0.05 | 0.06 | 0.05 | -0.04 |
| EPS Diluted Total Ops | -0.05 | 0.05 | 0.06 | 0.05 | -0.04 |
| EPS Diluted Continuous Ops | -0.05 | 0.05 | 0.06 | 0.05 | -0.04 |
| EBITDA(a) | $17,866 | $80,112 | $68,669 | $52,709 | $8,007 |